Specifically, patients initiating dapagliflozin vs those initiating GLP‐1RA were slightly younger and more often male, with a longer diabetes duration, lower BMI, higher fasting plasma glucose and HbA1c, better renal function, and more frequently were using metformin and insulin. This evidence concerns the gene INS and diabetes mellitus.